Spine unit modeling with high-throughput analysis (SUIT)
Part of Bones, joints & muscles clinical trials.
This study looks at cells from people with degenerated discs or from donated fat or placenta tissue. It aims to understand how these cells work and might help develop new treatments for back pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 30 and 60 years old if you have degenerative disc disease (DDD), or between 18 and 50 if you are donating fat or placenta tissue.
- You must be willing to sign a consent form to participate in the study.
- If you have DDD, you need to have a moderate to severe disc problem (Pfirrmann grade III-V) and be scheduled for spinal surgery.
- If you are donating fat tissue, you must be having surgery that removes fat (like a lipectomy).
- If you are donating placenta tissue, you must be pregnant or have given birth within the last 6 hours.
- You cannot have HIV, hepatitis B, hepatitis C, or syphilis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a treatment approach for people with long-lasting, painful worn-out discs in the lower back (and sometimes leg pain). It looks for people who tried common non-surgical options without enough relief and who may be headed toward a lumbar procedure.
This study tests if injecting a special cell therapy into a damaged spinal disc can reduce chronic low back pain. It is for people who have had low back pain for at least 6 months and haven't gotten enough relief from other treatments like physical therapy or pain medication.
This trial tests a new gene therapy called TG-C for people with chronic low back pain caused by degenerative disc disease. The goal is to see if it is safe and tolerable, and it might offer a new treatment option for those who haven't found relief from other therapies.
This study tests whether injecting a special disc material (nucleus pulposus allograft) into the damaged discs of your lower back can safely reduce pain and improve function. It's for people with long-term, moderate to severe low back pain from disc disease that hasn't gotten better with other treatments.
This trial studies specific neck (cervical) spine implants used during surgery for degenerative disc disease or neck instability, along with a particular kind of bone grafting and supporting hardware. It may help patients by testing whether these devices and the planned fusion approach work safely and effectively in real-world surgery.
This Phase 2 trial tests whether injecting your own stem cells into a few back discs can reduce chronic low back pain that has not improved with standard treatments. It may help by targeting disc-related (degenerative) wear seen on MRI, but it requires detailed MRI and blood test screening.
Hear when a new Degenerative Disc Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.